Home> Products> weight neutrality

{ "products": [ { "_id": "6961f2c52800555f6696ac8f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate 100 mg", "description": "GLISITAPTIN 100 is a pharmaceutical formulation containing Sitagliptin Phosphate 100 mg as its active ingredient. This medication represents a significant advancement in the management of type 2 diabetes mellitus, offering patients an effective oral treatment option that works through an innovative mechanism of action. As part of the DPP-4 inhibitor class of antidiabetic medications, GLISITAPTIN 100 has emerged as a trusted choice for healthcare providers and patients seeking reliable glycemic control with a favorable safety profile.\nThe brand name GLISITAPTIN 100 signifies quality, efficacy, and a commitment to helping individuals with type 2 diabetes achieve better health outcomes. Each tablet is precisely formulated to deliver the optimal therapeutic dose of sitagliptin phosphate, ensuring consistent and predictable results in blood sugar management.\nUnderstanding Sitagliptin Phosphate\nSitagliptin phosphate is a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor that has revolutionized diabetes treatment since its introduction. Unlike older diabetes medications that work through insulin secretion or glucose absorption mechanisms alone, sitagliptin operates through the incretin system—a natural bodily process that regulates blood glucose levels in response to food intake.\nThe 100 mg strength available in GLISITAPTIN 100 represents the standard therapeutic dose for most adult patients, providing optimal efficacy while maintaining an excellent safety margin. This once-daily formulation simplifies treatment regimens and promotes better adherence, which is crucial for long-term diabetes management success.\nHow GLISITAPTIN 100 Works\nGLISITAPTIN 100 works through a sophisticated yet elegant mechanism that harnesses your body's natural glucose regulation system. When you eat, your intestines release hormones called incretins, specifically GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These incretins have multiple beneficial effects: they stimulate insulin secretion from the pancreas, suppress glucagon release (which reduces glucose production by the liver), and slow gastric emptying.\nHowever, these beneficial incretins are rapidly broken down by an enzyme called DPP-4, limiting their glucose-lowering effects. GLISITAPTIN 100 inhibits this DPP-4 enzyme, allowing incretins to remain active in your bloodstream for longer periods. This results in better insulin secretion when blood glucose is elevated, reduced glucagon levels, and ultimately improved blood sugar control throughout the day.\nImportantly, because this mechanism is glucose-dependent, GLISITAPTIN 100 primarily works when blood sugar is elevated, which significantly reduces the risk of hypoglycemia (dangerously low blood sugar) compared to some other diabetes medications.\nPrimary Uses and Indications\nType 2 Diabetes Mellitus Management: GLISITAPTIN 100 is primarily indicated for improving glycemic control in adult patients with type 2 diabetes mellitus. It can be prescribed as:\n\nMonotherapy: As a first-line treatment for patients who cannot achieve adequate control through diet and exercise alone, particularly when metformin is contraindicated or not tolerated\nCombination Therapy: Alongside metformin, sulfonylureas, thiazolidinediones, or insulin when these medications alone do not provide sufficient glucose control\nTriple Therapy: In combination with two other antidiabetic agents when dual therapy fails to achieve target HbA1c levels\n\nThe medication is particularly suitable for patients who require effective glucose control but have concerns about weight gain or hypoglycemia, as GLISITAPTIN 100 is weight-neutral and has a low hypoglycemia risk when used as monotherapy.\nKey Benefits of GLISITAPTIN 100\n1. Effective Glycemic Control\nClinical studies have demonstrated that GLISITAPTIN 100 significantly reduces HbA1c levels (a measure of long-term blood sugar control) by approximately 0.5-1.0%, helping patients achieve and maintain target glucose levels. This improvement translates to reduced risk of diabetes-related complications over time.\n2. Low Hypoglycemia Risk\nUnlike sulfonylureas or insulin, GLISITAPTIN 100 has a glucose-dependent mechanism, meaning it primarily works when blood sugar is elevated. This dramatically reduces the risk of hypoglycemic episodes, providing patients with greater safety and peace of mind, especially important for elderly patients or those with unpredictable meal schedules.\n3. Weight Neutral\nGLISITAPTIN 100 does not cause weight gain, a significant advantage over some other diabetes medications like insulin, sulfonylureas, or thiazolidinediones. Maintaining a healthy body weight is crucial for overall diabetes management and cardiovascular health.\n4. Once-Daily Convenience\nThe single daily dose requirement of GLISITAPTIN 100 simplifies treatment regimens, making it easier for patients to maintain adherence. Better adherence directly correlates with improved glycemic control and better long-term outcomes.\n5. Pancreatic Preservation\nBy working through the incretin system, GLISITAPTIN 100 may help preserve pancreatic beta-cell function, potentially slowing the progression of type 2 diabetes. This represents a significant long-term benefit beyond simple glucose control.\n6. Cardiovascular Safety\nClinical trials have demonstrated cardiovascular safety with sitagliptin, an important consideration given that cardiovascular disease is the leading cause of morbidity and mortality in patients with type 2 diabetes.\n7. Renal Dosing Available\nWhile the 100 mg dose is standard, sitagliptin can be adjusted for patients with kidney impairment, making it accessible to a broader patient population, including those with diabetic nephropathy.\n8. Well-Tolerated\nGLISITAPTIN 100 generally has a favorable side effect profile, with most patients experiencing minimal adverse effects, contributing to better quality of life during treatment.\nDosage and Administration\nThe standard recommended dose of GLISITAPTIN 100 is one tablet taken orally once daily, with or without food. The medication can be taken at any time of day, though taking it at the same time daily helps establish a routine and ensures consistent blood levels.\nFor patients with moderate to severe kidney disease, dosage adjustments may be necessary. Your healthcare provider will determine the appropriate dose based on your kidney function tests. It's crucial to follow your doctor's instructions precisely and not adjust your dose without medical guidance.\nPotential Side Effects\nWhile GLISITAPTIN 100 is generally well-tolerated, like all medications, it may cause side effects in some individuals:\nCommon Side Effects (Affecting 1-10% of patients):\n\nUpper respiratory tract infections\nNasopharyngitis (common cold symptoms)\nHeadache\nNausea\nAbdominal pain\nDiarrhea\n\nThese side effects are typically mild and often resolve on their own as your body adjusts to the medication.\nLess Common but Serious Side Effects:\n\nPancreatitis: Severe abdominal pain that may radiate to the back, with or without vomiting, requires immediate medical attention\nSevere Joint Pain: Persistent, severe joint pain has been reported in some patients; inform your doctor if this occurs\nAllergic Reactions: Rare cases of serious allergic reactions including anaphylaxis, angioedema, and severe skin reactions have occurred\nHeart Failure: In patients with existing heart disease, worsening heart failure has been reported\nBullous Pemphigoid: A rare skin condition requiring discontinuation of the medication\n\nWhen Used with Other Diabetes Medications:\nWhen GLISITAPTIN 100 is combined with sulfonylureas or insulin, the risk of hypoglycemia increases. Your doctor may reduce the dose of these medications when adding GLISITAPTIN 100 to your regimen.\nPrecautions and Contraindications\nDo Not Use GLISITAPTIN 100 if:\n\nYou are allergic to sitagliptin or any ingredients in the formulation\nYou have type 1 diabetes or diabetic ketoacidosis\nYou are under 18 years of age (safety and efficacy not established)\n\nUse with Caution if:\n\nYou have a history of pancreatitis\nYou have kidney disease (dose adjustment required)\nYou have heart failure\nYou are pregnant or planning to become pregnant\nYou are breastfeeding\n\nImportant Patient Information\nMonitoring: Regular monitoring of blood glucose levels and HbA1c testing (typically every 3-6 months) is essential to assess treatment effectiveness and make necessary adjustments.\nLifestyle Factors: GLISITAPTIN 100 works best when combined with a healthy diet, regular physical activity, and weight management. Medication alone cannot substitute for comprehensive lifestyle management.\nMissed Dose: If you miss a dose, take it as soon as you remember on the same day. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Never double up doses.\nStorage: Store GLISITAPTIN 100 at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.\nDrug Interactions\nGLISITAPTIN 100 has few significant drug interactions, contributing to its safety profile. However, inform your healthcare provider about all medications, supplements, and herbal products you're taking. Particular attention should be paid to:\n\nOther diabetes medications (may require dose adjustments)\nDigoxin (levels may be slightly increased)\nMedications affecting kidney function\n\nConclusion\nGLISITAPTIN 100 (Sitagliptin Phosphate 100 mg) represents a modern, effective, and well-tolerated option for managing type 2 diabetes mellitus. Its innovative mechanism through the incretin system offers multiple advantages including effective glucose control, low hypoglycemia risk, weight neutrality, and once-daily convenience. These benefits make it an excellent choice for many patients, whether used alone or in combination with other antidiabetic medications.", "price": 464.0, "discountamount": 139.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2272, "imageuri": "https://productimages.withfloats.com/actual/6961f2c8ba33389b8e9f0122.png", "tileimageuri": "https://productimages.withfloats.com/tile/6961f2c8ba33389b8e9f0122.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-10T06:33:41.727Z", "updatedon": "2026-03-13T05:59:37.431Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-phosphate-100-mg/2272", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN 100", "category": "DIABETIC RANGE", "tags": [ "sitagliptin phosphate 100 mg tablet uses", "sitagliptin phosphate 100 mg dosage", "sitagliptin phosphate 100 mg side effects", "sitagliptin phosphate 100 mg benefits", "sitagliptin phosphate 100 mg price in india", "sitagliptin phosphate tablets 100 mg", "what is sitagliptin phosphate 100 mg used for", "how sitagliptin phosphate works in diabetes", "sitagliptin phosphate 100 mg for type 2 diabetes", "sitagliptin phosphate 100 mg mechanism of action", "sitagliptin phosphate tablet how to take", "medicine to control blood sugar sitagliptin", "tablet for post meal blood sugar control", "sitagliptin phosphate for high blood sugar", "can sitagliptin phosphate cause weight gain" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcb453ba48b3ee8857fd47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate Monhydrate 64.25 mg, Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 1 mg", "description": "ST GLIPTIN GM is a high-quality, fixed-dose combination oral antidiabetic medication containing Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg. This triple-combination therapy is specifically formulated to provide effective glycemic control in adults with type 2 diabetes mellitus (T2DM) who require multiple agents to achieve adequate blood sugar control.\nST GLIPTIN GM works through complementary mechanisms to target the core pathophysiological defects of T2DM—insulin resistance, impaired insulin secretion, and increased hepatic glucose output—making it an ideal choice for patients requiring intensified therapy.\nKey Indications:\nST GLIPTIN GM is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when dual therapy with any two of the individual components (Sitagliptin, Metformin, or Glimepiride) does not provide adequate control.\nMechanism of Action:\nSitagliptin (50 mg):\nA Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the levels of active incretin hormones (GLP-1 and GIP), increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner.\nMetformin Hydrochloride (1000 mg):\nA biguanide that improves insulin sensitivity by decreasing hepatic glucose production and enhancing peripheral glucose uptake.\nGlimepiride (1 mg):\nA sulfonylurea that stimulates pancreatic β-cells to secrete insulin, thereby reducing blood glucose levels.\nThe combination targets multiple metabolic pathways to provide synergistic and sustained blood glucose control.\nDosage and Administration:\nRecommended Dose:\nOne tablet daily, preferably with meals to reduce gastrointestinal side effects.\nIndividualization Required:\nDosage should be tailored based on patient response, renal function, and physician assessment.\nRenal Monitoring:\nBaseline and periodic assessment of renal function is advised, particularly due to the metformin component.\nKey Benefits of ST GLIPTIN GM 50/1000/1:\nTriple Mechanism of Action:\nTargets insulin resistance, insufficient insulin secretion, and excessive hepatic glucose production.\nEnhanced Glycemic Control:\nEffective in achieving and maintaining HbA1c targets.\nOnce-Daily Convenience:\nImproves adherence by reducing pill burden in patients requiring combination therapy.\nWeight Neutral to Modest Reduction:\nMetformin and sitagliptin components support weight neutrality.\nLow Hypoglycemia Risk:\nSitagliptin and metformin carry minimal hypoglycemia risk; however, glimepiride may increase the risk—monitor accordingly.\nSafety and Precautions:\nHypoglycemia:\nMay occur, particularly due to the glimepiride component. Educate patients on recognizing and managing low blood sugar.\nLactic Acidosis:\nA rare but serious complication of metformin. Avoid in patients with significant renal impairment or conditions predisposing to hypoxia.\nRenal Function:\nDose adjustment or discontinuation may be needed based on renal function.\nPancreatitis:\nRare reports with DPP-4 inhibitors like sitagliptin. Discontinue if suspected.\nAllergic Reactions:\nDiscontinue use if hypersensitivity reactions occur.\nPossible Side Effects:\nWhile ST GLIPTIN GM is generally well-tolerated, some patients may experience:\nNausea\nDiarrhea\nHeadache\nHypoglycemia (especially in elderly or with missed meals)\nAbdominal discomfort\nUpper respiratory tract infections\nDizziness\nFlatulence\nIf any side effects persist or worsen, seek immediate medical advice.\nStorage Instructions:\nStore at a temperature below 30°C.\nProtect from moisture and direct sunlight.\nKeep out of reach of children.\nWhy Choose ST GLIPTIN GM 50/1000/1?\nST GLIPTIN GM provides a powerful and synergistic combination of three well-established antidiabetic agents in a single, convenient daily dose. It offers a comprehensive approach to managing type 2 diabetes by addressing multiple metabolic abnormalities with a focus on safety, efficacy, and patient compliance. Manufactured under stringent GMP-certified conditions, ST GLIPTIN GM ensures quality, reliability, and therapeutic confidence for both patients and prescribers.", "price": 285.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2188, "imageuri": "https://productimages.withfloats.com/actual/68fcb456f31288eaa96accfa.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fcb456f31288eaa96accfa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T11:28:19.425Z", "updatedon": "2026-03-13T10:40:20.1Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-phosphate-monhydrate-64-25-mg-sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-1-mg/2188", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+1", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg", "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg", "type 2 diabetes mellitus (T2DM)", "blood sugar control" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "681c5e9e5a26e4010ea42029", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sitagliptin and metformin hydrochloride tablets", "description": "ST-GLIPTIN M 100/1000 is an advanced oral antidiabetic medication designed for the effective management of Type 2 Diabetes Mellitus. This powerful combination of Sitagliptin (100 mg) and Metformin Hydrochloride (1000 mg) offers dual action in controlling elevated blood glucose levels, especially in patients who do not respond adequately to metformin or sitagliptin alone. It is intended for adults and is generally used in conjunction with diet and exercise to enhance glycemic control.\n\nKey Ingredients\nSitagliptin (100 mg)\nSitagliptin is a DPP-4 (Dipeptidyl Peptidase-4) inhibitor that increases the levels of incretin hormones, which help regulate blood sugar by increasing insulin release and decreasing glucagon levels.\n\nMetformin Hydrochloride (1000 mg)\nMetformin belongs to the biguanide class of antidiabetics. It works by reducing the amount of sugar produced by the liver and improves the body’s sensitivity to insulin, facilitating better glucose utilization.\n\nKey Benefits\nHelps reduce both fasting and postprandial (after-meal) blood glucose levels effectively\nImproves overall glycemic control in patients with Type 2 diabetes\nCombines two different mechanisms of action for better diabetes management\nMinimizes the risk of hypoglycemia compared to other antidiabetic therapies\nMay support weight neutrality or slight weight loss in diabetic individuals\n\nHow Does It Work?\nST-GLIPTIN M 100/1000 works through a synergistic mechanism by combining two effective antidiabetic agents:\n\nSitagliptin enhances the levels of incretin hormones, which help the pancreas produce more insulin and reduce the secretion of glucagon, especially when blood sugar is high.\nMetformin reduces hepatic glucose production and increases insulin sensitivity, which helps the body use glucose more efficiently.\nTogether, these agents provide comprehensive blood sugar control by addressing multiple physiological pathways involved in glucose metabolism.\n\nDirections for Use\nTake ST-GLIPTIN M 100/1000 exactly as prescribed by your physician.\nIt is typically taken once or twice daily with meals to reduce gastrointestinal side effects and optimize absorption.\nSwallow the tablet whole with water. Do not crush or chew the tablet.\nMaintain a balanced diet and follow an active lifestyle for best results.\nRegular blood sugar monitoring is essential to assess effectiveness and make any necessary dosage adjustments.\n\nSide Effects\nCommon side effects may include nausea, diarrhea, stomach upset, or headache.\nSome individuals may experience respiratory tract infections, sore throat, or a runny nose.\nLactic acidosis is a rare but serious side effect associated with high-dose metformin—seek immediate medical attention if symptoms like unusual fatigue, muscle pain, difficulty breathing, or abdominal discomfort occur.\nAllergic reactions such as rash, itching, or swelling are uncommon but possible.\nAlways inform your doctor of any persistent or bothersome side effects for timely intervention.", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "1001000 works", "100 1000stgliptin", "work stgliptin", "balanced diet", "tablet maintain", "diabetic individuals", "sitagliptin 100 mg", "timely intervention", "rash itching", "medical attention", "highdose metforminseek", "assess effectiveness", "active lifestyle", "pancreas produce", "synergistic mechanism", "antidiabetic therapies", "hypoglycemia compared", "glycemic control", "biguanide class", "incretin hormones", "respond adequately", "powerful combination", "insulin facilitating", "sugar produced", "side effect", "bodys sensitivity", "effective management", "blood sugar", "increases insulin sensitivity", "regulate blood sugar", "glucose metabolism directions", "increasing insulin release", "bothersome side effects", "diabetes management minimizes", "optimize absorption swallow", "slight weight loss", "support weight neutrality" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2107, "imageuri": "https://productimages.withfloats.com/actual/681c5e9f5e6dd8f19a0309c3.png", "tileimageuri": "https://productimages.withfloats.com/tile/681c5e9f5e6dd8f19a0309c3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-08T07:34:54.516Z", "updatedon": "2026-03-13T10:19:42.388Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-and-metformin-hydrochloride-tablets/2107", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST-GLIPTIN M 100/ 1000", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin and Metformin hydrochloride tablets Uses in Hindi", "sitagliptin and metformin hydrochloride tablets 50/1000 uses in hindi", "sitagliptin and metformin hydrochloride tablets", "sitagliptin and metformin hydrochloride uses in hindi", "sitagliptin and metformin hydrochloride uses", "sitagliptin and metformin hydrochloride tablets.", "sitagliptin and metformin tablets.", "sitagliptin and metformin combination.", "sitagliptin and metformin uses", "sitagliptin and metformin hydrochloride uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a2708da3a81d5c6a169f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STERIS SITAGLIPTIN 50 + METFORMIN 500 ", "description": "STERIS SITAGLIPTIN 50 + METFORMIN 500 \nSitagliptin (50mg) & Metformin HCI (500mg)\nIntroduction to STERIS SITAGLIPTIN 50 + METFORMIN 500\nSTERIS SITAGLIPTIN 50 + METFORMIN 500 is a combination medication that includes Sitagliptin 50mg and Metformin Hydrochloride 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, this medication offers comprehensive glycemic control, helping patients effectively manage their blood sugar levels.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps control blood sugar levels by enhancing the body's ability to regulate insulin after meals. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones that play a significant role in glucose metabolism.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. Metformin is a cornerstone in the management of type 2 diabetes due to its effectiveness and safety profile.\n\nBenefits of STERIS SITAGLIPTIN 50 + METFORMIN 500\nEffective Blood Sugar Management\nDual Mechanism of Action: Sitagliptin enhances insulin release and reduces glucagon levels after meals, while Metformin improves insulin sensitivity and reduces hepatic glucose production, providing comprehensive glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: STERIS SITAGLIPTIN 50 + METFORMIN 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, this medication can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLow Risk of Hypoglycemia: When used alone or in combination with Metformin, Sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use STERIS SITAGLIPTIN 50 + METFORMIN 500\nDosage and Administration\nRecommended Dosage: The typical dosage is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take the medication regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/steris-sitagliptin-50-metformin-500-134361", "price": 285.0, "discountamount": 85.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "body", "liver", "Order", "EMAIL", "meals", "water", "amount", "Action", "option", "Support", "ability", "readings", "Low Risk", "Overview", "biguanide", "neuropathy", "one tablet", "overweight", "full glass", "Guidelines", "information", "Optimal Use", "utilization", "cornerstone", "retinopathy", "Adjustments", "Introduction", "Postprandial", "Reduced Risk", "best results", "sterisonline", "instructions", "DPP-4 enzyme", "Hypoglycemia", "sterispharma", "Metformin HCI", "effectiveness", "CALL/WHATSAPP", "Dual Mechanism", "Administration", "typical dosage", "obese patients", "Consistent Use", "treatment plan", "safety profile", "insulin release", "glucagon levels", "DPP-4) inhibitor", "significant role", "Sitagliptin 50mg", "Exercise Adjunct", "excellent adjunct", "incretin hormones", "weight neutrality", "Weight Management", "prolonged activity", "glucose metabolism", "STERIS SITAGLIPTIN", "Recommended Dosage", "modest weight loss", "blood sugar control", "insulin sensitivity", "Diabetes Management", "healthcare provider", "individual response", "combination medication", "cardiovascular disease", "dipeptidyl peptidase-4", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "Metformin Hydrochloride", "complementary mechanisms", "type 2 diabetes mellitus", "peripheral glucose uptake", "stable blood sugar levels", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "gastrointestinal discomfort", "comprehensive glycemic control", "Effective Blood Sugar Management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1468, "imageuri": "https://productimages.withfloats.com/actual/6661a271487c46164ce5354d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661a271487c46164ce5354d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T11:50:08.381Z", "updatedon": "2026-03-13T09:50:27.092Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//steris-sitagliptin-50-metformin-500-/1468", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STERIS SITAGLIPTIN 50 + METFORMIN 500 ", "category": "DIABETIC RANGE", "tags": [ "STERIS SITAGLIPTIN 50", "METFORMIN 500", "Sitagliptin (50mg)", "Metformin HCI (500mg)", "Metformin HCl", "Metformin side effects", "Metformin hydrochloride tablet uses", "Metformin Hydrochloride Tablets IP 500mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661967ed91d281c30c75747", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ST-GLIPTIN M 50/500 ", "description": "ST-GLIPTIN M 50/500 \nSitagliptin (50mg), Metformin SR 500\nIntroduction to ST-GLIPTIN M 50/500\nST-GLIPTIN M 50/500 is a combination medication that includes Sitagliptin 50mg and Metformin Hydrochloride Sustained Release (SR) 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, ST-GLIPTIN M 50/500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps control blood sugar levels by enhancing the body's ability to regulate insulin after meals. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones that play a significant role in glucose metabolism.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of ST-GLIPTIN M 50/500\nEffective Blood Sugar Management\nDual Mechanism of Action: Sitagliptin enhances insulin release and reduces glucagon levels after meals, while Metformin improves insulin sensitivity and reduces hepatic glucose production, providing comprehensive glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: ST-GLIPTIN M 50/500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, ST-GLIPTIN M 50/500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLow Risk of Hypoglycemia: When used alone or in combination with Metformin, Sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use ST-GLIPTIN M 50/500\nDosage and Administration\nRecommended Dosage: The typical dosage of ST-GLIPTIN M 50/500 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take ST-GLIPTIN M 50/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/st-gliptin-m-50-500-134013", "price": 414.9, "discountamount": 124.47, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "Order", "EMAIL", "meals", "water", "liver", "Action", "amount", "option", "ability", "Support", "Overview", "Low Risk", "readings", "biguanide", "one tablet", "neuropathy", "Guidelines", "full glass", "overweight", "utilization", "Adjustments", "Optimal Use", "information", "Sitagliptin", "retinopathy", "instructions", "Introduction", "Metformin SR", "Postprandial", "sterispharma", "Reduced Risk", "best results", "Hypoglycemia", "sterisonline", "DPP-4 enzyme", "effectiveness", "CALL/WHATSAPP", "Consistent Use", "Dual Mechanism", "obese patients", "typical dosage", "Administration", "treatment plan", "glucagon levels", "insulin release", "DPP-4) inhibitor", "prolonged effect", "significant role", "Exercise Adjunct", "excellent adjunct", "incretin hormones", "weight neutrality", "Weight Management", "prolonged activity", "Recommended Dosage", "modest weight loss", "glucose metabolism", "Diabetes Management", "healthcare provider", "individual response", "insulin sensitivity", "blood sugar control", "ST-GLIPTIN M 50/500", "cardiovascular disease", "combination medication", "dipeptidyl peptidase-4", "Fasting Glucose Control", "lifestyle modifications", "long-term complications", "complementary mechanisms", "type 2 diabetes mellitus", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "other diabetes medications", "hepatic glucose production", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "Effective Blood Sugar Management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1457, "imageuri": "https://productimages.withfloats.com/actual/666196810c19ea48b9489473.png", "tileimageuri": "https://productimages.withfloats.com/tile/666196810c19ea48b9489473.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:59:10.485Z", "updatedon": "2026-03-13T06:53:47.01Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//st-gliptin-m-50-500-/1457", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST-GLIPTIN M 50/500 ", "category": "DIABETIC RANGE", "tags": [ "ST-GLIPTIN M 50/500", "Sitagliptin (50mg)", "Metformin SR 500", "Metformin sr 500 side effects", "Metformin SR 500 uses", "", "Metformin SR 500 price", "Glycomet SR 500 weight loss" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666195738da3a81d5c6a12e7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ST-GLIPTIN M50/1000 ", "description": "ST-GLIPTIN M50/1000 \nSitagliptin (50mg), Metformin SR 1000\nIntroduction to ST-GLIPTIN M50/1000\nST-GLIPTIN M50/1000 is a combination medication that includes Sitagliptin 50mg and Metformin Hydrochloride Sustained Release (SR) 1000mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, ST-GLIPTIN M50/1000 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps control blood sugar levels by enhancing the body's ability to regulate insulin after meals. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones that play a significant role in glucose metabolism.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of ST-GLIPTIN M50/1000\nEffective Blood Sugar Management\nDual Mechanism of Action: Sitagliptin enhances insulin release and reduces glucagon levels after meals, while Metformin improves insulin sensitivity and reduces hepatic glucose production, providing comprehensive glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: ST-GLIPTIN M50/1000 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, ST-GLIPTIN M50/1000 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLow Risk of Hypoglycemia: When used alone or in combination with Metformin, Sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use ST-GLIPTIN M50/1000\nDosage and Administration\nRecommended Dosage: The typical dosage of ST-GLIPTIN M50/1000 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take ST-GLIPTIN M50/1000 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/st-gliptin-m50-1000-134014", "price": 570.0, "discountamount": 171.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "Order", "EMAIL", "meals", "water", "liver", "Action", "amount", "option", "ability", "Support", "Overview", "Low Risk", "readings", "biguanide", "one tablet", "full glass", "overweight", "neuropathy", "Guidelines", "Sitagliptin", "information", "retinopathy", "utilization", "Adjustments", "Optimal Use", "instructions", "Hypoglycemia", "Introduction", "Metformin SR", "Postprandial", "sterispharma", "Reduced Risk", "best results", "sterisonline", "DPP-4 enzyme", "CALL/WHATSAPP", "effectiveness", "obese patients", "treatment plan", "Administration", "Dual Mechanism", "typical dosage", "Consistent Use", "glucagon levels", "insulin release", "prolonged effect", "significant role", "Exercise Adjunct", "DPP-4) inhibitor", "weight neutrality", "excellent adjunct", "Weight Management", "incretin hormones", "glucose metabolism", "modest weight loss", "Recommended Dosage", "prolonged activity", "healthcare provider", "ST-GLIPTIN M50/1000", "insulin sensitivity", "blood sugar control", "Diabetes Management", "individual response", "combination medication", "cardiovascular disease", "dipeptidyl peptidase-4", "lifestyle modifications", "Fasting Glucose Control", "long-term complications", "complementary mechanisms", "type 2 diabetes mellitus", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "other diabetes medications", "hepatic glucose production", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "Effective Blood Sugar Management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1456, "imageuri": "https://productimages.withfloats.com/actual/66619576c06ee12d88d00a83.png", "tileimageuri": "https://productimages.withfloats.com/tile/66619576c06ee12d88d00a83.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:54:43.645Z", "updatedon": "2026-03-13T06:53:11.53Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//st-gliptin-m50-1000-/1456", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST-GLIPTIN M50/1000 ", "category": "DIABETIC RANGE", "tags": [ "ST-GLIPTIN M50/1000", "Sitagliptin (50mg)", "Metformin SR 1000", "Sitagliptin 50 mg dose", "Sitagliptin side effects", "Sitagliptin 50 mg price", "Sitagliptin 50 mg generic" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66619278db9fdd21801ef284", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " Glimepiride, Metformin SR Sustained Release, and Voglibose", "description": "SEIZMET TRIO 0.3 \nGlimepiride (2mg), Metformin SR (500mg), Voglibose (0.3mg)\nIntroduction to SEIZMET TRIO 0.3\nSEIZMET TRIO 0.3 is a combination medication that includes Glimepiride 2mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Voglibose 0.3mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Voglibose, SEIZMET TRIO 0.3 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Voglibose?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Voglibose\nVoglibose is an alpha-glucosidase inhibitor that helps control blood sugar levels by slowing the digestion and absorption of carbohydrates in the small intestine. This leads to a slower and lower rise in blood glucose levels after meals.\n\nBenefits of SEIZMET TRIO 0.3\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Voglibose slows carbohydrate absorption. This comprehensive approach offers robust glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET TRIO 0.3 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET TRIO 0.3 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nImproved Glycemic Control: Voglibose’s action on slowing carbohydrate absorption leads to better control over postprandial spikes, contributing to overall glycemic stability.\nHow to Use SEIZMET TRIO 0.3\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET TRIO 0.3 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Voglibose. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET TRIO 0.3 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now", "price": 156.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "3", "day", "body", "Diet", "EMAIL", "Order", "liver", "water", "meals", "amount", "slower", "option", "Action", "Support", "Overview", "pancreas", "readings", "digestion", "biguanide", "Voglibose", "one tablet", "lower rise", "overweight", "Guidelines", "full glass", "neuropathy", "utilization", "Adjustments", "information", "retinopathy", "Optimal Use", "Introduction", "Metformin SR", "SEIZMET TRIO", "best results", "sterisonline", "Reduced Risk", "instructions", "sterispharma", "sulfonylurea", "effectiveness", "CALL/WHATSAPP", "carbohydrates", "Administration", "obese patients", "typical dosage", "treatment plan", "Consistent Use", "Glimepiride 2mg", "small intestine", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "excellent adjunct", "Weight Management", "weight neutrality", "insulin secretion", "Recommended Dosage", "modest weight loss", "blood sugar control", "Diabetes Management", "individual response", "postprandial spikes", "healthcare provider", "insulin sensitivity", "blood glucose levels", "pancreatic beta cells", "cardiovascular disease", "combination medication", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "robust glycemic control", "lifestyle modifications", "carbohydrate absorption", "type 2 diabetes mellitus", "complementary mechanisms", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "overall glycemic stability", "alpha-glucosidase inhibitor", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1453, "imageuri": "https://productimages.withfloats.com/actual/6661927b487c46164ce4b1f6.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661927b487c46164ce4b1f6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:42:00.595Z", "updatedon": "2026-03-13T06:32:38.939Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//-glimepiride-metformin-sr-sustained-release-and-voglibose/1453", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET TRIO 0.3 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET TRIO 0.3", "Glimepiride (2mg)", "Metformin SR (500mg)", "Voglibose (0.3mg)", "Glimepiride 2mg side effects", "glimepiride + metformin", "Glimepiride 2mg price", "Glimepiride 2mg Uses in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666191664515df1748621e0b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride 2mg, Metformin SR 500mg, Voglibose 0.2mg", "description": "SEIZMET TRIO 0.2 \nGlimepiride (2mg), Metformin SR (500mg), Voglibose (0.2mg)\nIntroduction to SEIZMET TRIO 0.2\nSEIZMET TRIO 0.2 is a combination medication that includes Glimepiride 2mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Voglibose 0.2mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Voglibose, SEIZMET TRIO 0.2 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Voglibose?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Voglibose\nVoglibose is an alpha-glucosidase inhibitor that helps control blood sugar levels by slowing the digestion and absorption of carbohydrates in the small intestine. This leads to a slower and lower rise in blood glucose levels after meals.\n\nBenefits of SEIZMET TRIO 0.2\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Voglibose slows carbohydrate absorption. This comprehensive approach offers robust glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET TRIO 0.2 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET TRIO 0.2 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nImproved Glycemic Control: Voglibose’s action on slowing carbohydrate absorption leads to better control over postprandial spikes, contributing to overall glycemic stability.\nHow to Use SEIZMET TRIO 0.2\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET TRIO 0.2 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Voglibose. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET TRIO 0.2 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-trio-0-2-133445", "price": 155.9, "discountamount": 46.77, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "Diet", "body", "liver", "meals", "water", "Order", "EMAIL", "option", "amount", "slower", "Action", "Support", "readings", "Overview", "pancreas", "Improved", "Voglibose", "digestion", "biguanide", "neuropathy", "full glass", "lower rise", "overweight", "one tablet", "Guidelines", "information", "Adjustments", "retinopathy", "utilization", "Optimal Use", "Metformin SR", "best results", "Introduction", "SEIZMET TRIO", "sterisonline", "Reduced Risk", "instructions", "sterispharma", "sulfonylurea", "effectiveness", "CALL/WHATSAPP", "carbohydrates", "Administration", "obese patients", "typical dosage", "treatment plan", "Consistent Use", "Glimepiride 2mg", "small intestine", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "excellent adjunct", "Weight Management", "weight neutrality", "insulin secretion", "Recommended Dosage", "modest weight loss", "blood sugar control", "Diabetes Management", "individual response", "postprandial spikes", "healthcare provider", "insulin sensitivity", "blood glucose levels", "pancreatic beta cells", "cardiovascular disease", "combination medication", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "robust glycemic control", "lifestyle modifications", "carbohydrate absorption", "type 2 diabetes mellitus", "complementary mechanisms", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "overall glycemic stability", "alpha-glucosidase inhibitor", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1452, "imageuri": "https://productimages.withfloats.com/actual/6661916a8e77bb2c7156e563.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661916a8e77bb2c7156e563.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:37:26.597Z", "updatedon": "2026-03-13T06:31:35.361Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-2mg-metformin-sr-500mg-voglibose-0-2mg/1452", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET TRIO 0.2 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET TRIO 0.2", "Glimepiride (2mg)", "Metformin SR (500mg)", "Voglibose (0.2mg)", "Glimepiride 2mg side effects", "glimepiride + metformin", "Glimepiride 2mg price", "Glimepiride 2mg Uses in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66619067161afa2274ff4f3b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Metformin SR 850mg", "description": "SEIZMET SR 850 \nMetformin SR (850mg) \nIntroduction to SEIZMET SR 850\nSEIZMET SR 850 contains Metformin Hydrochloride 850mg in a sustained-release (SR) formulation. This medication is primarily used for the management of type 2 diabetes mellitus. Metformin belongs to a class of drugs known as biguanides, which help control blood sugar levels by improving the body's response to insulin. The sustained-release formulation ensures a prolonged effect throughout the day, providing steady glycemic control.\n\nWhat is Metformin?\nOverview of Metformin\nMetformin is an oral diabetes medication that helps lower blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver. It also enhances glucose uptake and utilization in peripheral tissues, making it an effective treatment for type 2 diabetes.\n\nMechanism of Action\nInsulin Sensitization: Metformin works by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues, allowing cells to absorb glucose more effectively.\nGlucose Uptake: By enhancing insulin sensitivity, Metformin helps muscles and adipose tissues take up glucose from the bloodstream, lowering blood sugar levels.\nReduced Glucose Production: Metformin decreases the amount of glucose produced by the liver, contributing to overall glycemic control.\nBenefits of SEIZMET SR 850\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: SEIZMET SR 850 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting both insulin sensitivity and hepatic glucose production, Metformin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET SR 850 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET SR 850 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Neutral or Loss: Unlike some other diabetes medications, Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nCardiovascular Benefits: Metformin has been shown to have beneficial effects on cardiovascular health, reducing the risk of heart disease and stroke in patients with type 2 diabetes.\nHow to Use SEIZMET SR 850\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET SR 850 is one tablet taken once daily with the evening meal. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET SR 850 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-sr-850-133444", "price": 43.0, "discountamount": 13.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "cells", "class", "Order", "EMAIL", "drugs", "water", "meals", "liver", "amount", "Action", "stroke", "option", "Support", "muscles", "readings", "Overview", "biguanides", "full glass", "one tablet", "neuropathy", "overweight", "Guidelines", "bloodstream", "utilization", "information", "retinopathy", "Optimal Use", "Adjustments", "Metformin SR", "Introduction", "sterispharma", "Reduced Risk", "best results", "evening meal", "sterisonline", "heart disease", "CALL/WHATSAPP", "SEIZMET SR 850", "glucose uptake", "Consistent Use", "Administration", "Weight Neutral", "obese patients", "typical dosage", "treatment plan", "unique mechanism", "Exercise Adjunct", "prolonged effect", "excellent adjunct", "Recommended Dosage", "modest weight loss", "peripheral tissues", "beneficial effects", "blood sugar control", "individual response", "Diabetes Management", "effective treatment", "healthcare provider", "insulin sensitivity", "cardiovascular health", "Insulin Sensitization", "cardiovascular disease", "Metformin Hydrochloride", "steady glycemic control", "Cardiovascular Benefits", "long-term complications", "lifestyle modifications", "type 2 diabetes mellitus", "overall glycemic control", "oral diabetes medication", "stable blood sugar levels", "Reduced Glucose Production", "Additional Health Benefits", "hepatic glucose production", "other diabetes medications", "gastrointestinal discomfort", "sustained-release formulation", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "sustained-release (SR) formulation", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1451, "imageuri": "https://productimages.withfloats.com/actual/66619068c06ee12d88cfeb92.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66619068c06ee12d88cfeb92.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:33:11.434Z", "updatedon": "2026-03-13T06:30:27.801Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-sr-850mg/1451", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET SR 850 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET SR 850", "Metformin SR (850mg)", "Glycomet 850 SR in pregnancy", "Glycomet SR 850 composition", "Glycomet SR 850 side effects", "Metformin 850 mg price", "Glycomet 850 SR uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }